Dnazymes As Novel Therapeutics

Authors

  • K.BABUNAGESWARARAO Department of Pharmaceutics, Banaras Hindu University, Varanasi, India-221005.
  • R.RAMAKRISHNA Department of Pharmacy, Birla Institute of Technological Sciences, Pilani, Rajasthan, India- 333031.
  • P.D.KAMAL KUMAR JSS College of Pharmacy, Ooty, Tamilnadu-643001.
  • SYED SAMEER Nalanda College of Pharmacy, Charlapalli, Nalgonda, India -508001

Keywords:

DNAzymes, Cardiovascular, Tumerogenic, ribozymes.

Abstract

DNAzymes are the catalytic DNA molecules which are single stranded with enzymatic activity. Many deoxyribozymes  catalyses DNA phosphorylation, DNA adenylation, DNA deglycosylationporphyrin metallationthymine dimer photo reversion and DNA cleavage, act as catalysts in asymmetric synthesis.  10–23 DNAzymes are known for their excellent catalytic efficiency. Similar to other antisense molecules, DNAzymes are prone to nucleolytic degradation in body fluids. To prolong the half-life of oligonucleotides for in-vivo usage, to enhance biostability, to reduce toxicity and improve target affinity modified nucleotides are usually incorporated. Even with certain advantages and limitations for DNAzymes, they find wide applications in medicine and therapeutics like in cardiovascular, cancer, anti-bacterials, pain, brain disorders etc. In present study we have focused on the structure of first DNAzyme, its advantages, and various applications of the DNAzymes.

Published

31.12.2011

How to Cite

K.BABUNAGESWARARAO, R.RAMAKRISHNA, P.D.KAMAL KUMAR, & SYED SAMEER. (2011). Dnazymes As Novel Therapeutics. International Journal of Pharma and Bio Sciences, 2(4), 161–173. Retrieved from https://ijpbs.net/index.php/journal/article/view/1010

Issue

Section

Research Articles

Categories